Nuvo Research Inc. - News Releases

News releases may contain forward-looking statements, subject to risks and uncertainties beyond Nuvo's control. All news releases were accurate when issued. Actual results could differ materially from those expressed and Nuvo undertakes no obligation to revise the information in light of future events.

Year: 2009 : 2008 : 2007 : 2006 : 2005 : 2004

Dec 22nd, 2005	Nuvo Research Inc. Acquires fqubed
Dec 22nd, 2005	Nuvo Research Inc. Reports Successful Pennsaid Phase III Clinical Trial Results
Dec 15th, 2005	Nuvo Research Inc. Forms Panel of FDA Experts
Oct 31st, 2005	Nuvo Research Inc. Begins Trading Under New TSX Symbol "NRI"
Oct 12th, 2005	Nuvo Announces First Quarter 2006 Results
Oct 11th, 2005	Nuvo Research Inc. release of first quarter fiscal 2006 financial results and conference call
Sept 21st, 2005	Dimethaid Research Inc. to be Renamed Nuvo Research Inc. Reflecting New Direction
Sept 19th, 2005	Dimethaid Creates Scientific Advisory Board
Aug 31st, 2005	Dimethaid Proposes Name Change to Nuvo Research
Aug 24th, 2005	Dimethaid Announces New Pancreatic Cancer Trial with WF10
Aug 19th, 2005	Dimethaid Announces Year-End and Fourth Quarter Results
Aug 16th, 2005	Paladin Labs to Acquire Canadian License to Pennsaid
July 25th, 2005	Dimethaid Announces New Appointment
July 7th, 2005	Dimethaid develops "PENNSAID(R) PLUS": An innovative new formulation for PENNSAID(R)
May 25th, 2005	Dimethaid receives favourable PMPRB ruling
April 14th, 2005	Dimethaid Announces Third Quarter Financial Results (en français)
March 30th, 2005	Dimethaid Receives PMPRB Update
February 7th, 2005	Dimethaid Settles Outstanding Obligations of Subsidiary Dimethaid International Inc.
January 14th, 2005	Dimethaid announces second quarter financial results
January 4th, 2005	Dimethaid and Solvay Finalize Agreement to Market Arthritis Drug in Canada (en français)

All news releases are in PDF format. To view the news releases you will need Adobe Acrobat Reader installed on your computer.